Synchronous resection of primary colorectal tumor, liver metastases safe in some patients
the ONA take:
A recent study examined and compared patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.
Generally, a combination therapy involving chemotherapy and surgical resection is used to treat colorectal cancer, but debate remains as to whether metastatic tumors should be surgically removed at the same time as the primary tumors (synchronously), as opposed to a sequential approach.
Researchers from the Mayo Clinic, led by David Nagorney, M.D., used a multi-institutional database to review a pool of 43,408 patients who underwent colorectal and liver resections for stage IV colorectal cancer. Individuals in the pool were assigned risk categories based on the extent of resection, as well as colorectal resection location.
The investigators compared outcomes within each category, comparing those that underwent synchronous colorectal and liver resections vs those who had these operations performed sequentially. The study goal was to evaluate the risk of the component operations and determine which combination of colon and liver procedures was safest.
Study data indicate that poor patient outcomes are tied more closely to the risk of individual procedures as opposed to timing. major complications are linked to the extent of resection required (liver resection or colorectal surgery).
The study data also indicate that synchronous resection of primary colorectal tumors and metastatic liver tumors is safe when minor liver resections are required.
Study results were published in Journal of Gastrointestinal Surgery.
Patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|